癌症疫苗的未来针对结直肠癌的癌症疫苗

相关实验视频

Updated: Jun 28, 2025

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Wenqing Jia^1,2, Xiaonan Shen³, Zichao Guo^1,2

¹Department of General Surgery, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Expert opinion on biological therapy

|April 22, 2024

概括

结肠直肠癌疫苗有望增强抗瘤免疫力,特别是当与微观卫星稳定患者的免疫检查点抑制剂相结合时. 对最佳疫苗设计和生物标志物的进一步研究对于临床成功至关重要.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
目前的免疫检查点抑制剂 (ICI) 对由于免疫透不足而导致不匹配修复缺陷/微卫星不稳定 (dMMR/MSI) CRC 的有限部分患者有益.
癌症疫苗提供了一种策略,在瘤微环境中诱导瘤特异性免疫力.

研究的目的:

在过去三年中,审查结肠直肠癌 (CRC) 疫苗的最新进展.
探索CRC疫苗开发和应用的有希望的未来方向.

主要方法:

在过去三年内发表的关于CRC疫苗的当前文献的综述.
分析有效疫苗制造的关键组成部分,包括新抗原和输送平台.
讨论潜在的应用,包括辅助疗法和预防策略.

主要成果:

癌症疫苗是CRC的一个有希望的治疗途径,特别是作为标准治疗的辅助剂.
与癌症疫苗和ICI结合治疗对微卫星稳定的CRC患者具有潜力.
最佳的疫苗设计需要免疫性新抗原,高HLA结合亲和力和有效的输送系统.

结论:

癌症疫苗是一个令人兴奋的研究领域,有可能成为CRC治疗指南的宝贵补充.
对预测患者反应和预后结果的生物标志物的进一步研究是有必要的.
开发用于预防CRC的预防性疫苗也是未来探索的一个领域.

关键词:

结肠直肠癌是一种癌症.树突细胞疫苗树突细胞疫苗免疫疗法免疫疗法纳米疫苗的使用方法新抗原是一种新抗原.疫苗疫苗疫苗疫苗

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...